LumaCyte

Revolutionizing advanced therapies with precise, predictive, label-free insights, LumaCyte sets the standard for cell analytics.

LumaCyte is redefining advanced therapies with its groundbreaking cellular Process Analytical Technology (PAT). Our mission is clear: reliable monitoring and quantification of cell processes throughout biomanufacturing is foundational for successful therapeutics , and we deliver this through a single, transformative platform. At the heart of our innovation is Laser Force Cytology™ (LFC™), the core technology powering the Radiance® instrument, which provides precise, label-free cell analytics in near real-time, while enabling predictive insights into downstream processes. 

Radiance® consolidates the qualification of starting materials, in-process monitoring, potency assessment, and product release assays, all under one hood of an instrument with full GMP compliance. This integrated approach streamlines workflows, reduces complexity, and accelerates time-to-market for life-saving therapies. By leveraging predictive insights across manufacturing, we empower organizations to make data-driven decisions that enhance consistency, safety, and efficacy.

LumaCyte’s technology represents the future of QC analytics by reducing subjectivity and minimizing sample preparation. Ease of use is central to our design philosophy. Our instrument is easily operable by early-career professionals without an advanced degree, reducing training burdens and expanding workforce accessibility. This simplicity, combined with robust analytical power, makes LumaCyte an indispensable partner for modern biomanufacturing.

With LumaCyte, we provide more than an instrument, we provide predictive, transformative capabilities that drive quality and innovation across the entire biomanufacturing lifecycle. We are committed to enabling the next generation of therapeutics through smarter, faster, and more reliable cell analytics.